ClinicalTrials.gg
CompletedNCT03309748Updated Dec 17, 2024

Phototherapy Remediation of Black Stain

An interventional study of Dental prophylaxis and Dental prophylaxis + antimicrobial photodynamic therapy in Dental Deposits, Tooth Discoloration and Dental Prophylaxis, sponsored by Cardenal Herrera University. Completed. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-17.

Sponsored by Cardenal Herrera University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was Apr 2016, 10 years 6 months ago, and no results have been posted to the registry.
  • Registered 3 years 4 months after the study started (first participant enrolled May 2014, registered Oct 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study investigates the remediation of black-stained tooth surfaces using antimicrobial photodynamic therapy. In this crossover trial, a cohort of patients received standard dental prophylactic cleaning to remove the black stain. Later, following the washout period, (reappearance of the black stain) received photodynamic therapy in addition to the standard cleaning. Stain-free period in each of the arms was the main outcome variable. Additional microbial plaque testing was also carried out.

Read the detailed description

The standard treatment practice for black dental stain is dental prophylaxis, however this is often harmful to the enamel surface and can result in tooth sensitivity. In this study we aim to explore the application of antimicrobial photodynamic therapy (aPDT) for the treatment of adult black dental stain. aPDT has demonstrated positive results in the treatment of periodontitis.

Patients received an oral examination and the extent of black stain was scored (score 1, pigmented spots or incomplete lines parallel to the gingival margin, score 2: solid lines pigmented, readily observable and limited to the cervical third of the tooth surface, score 3: pigmentation extending beyond the cervical third). The patients' oral cavity was photographed in sextants, along with a complete picture of the jaw (lingual plane) and the maxillary arch (palatal plane). For bacterial analysis, 1mg of black plaque was collected by scraping with a plastic scaler from buccal tooth surfaces taking care to avoid unnecessary removal of enamel hydroxyapatite. The first dental prophylaxis was performed to remove the black stain.

Patients were reviewed monthly and in each visit, were photographed as previously described, and the level of pigmentation scored according to the mentioned criteria. The monthly visits were continued until the black stain score returned to the initial value. The period between the first and the last appointment was noted. At this point, each volunteer received dental prophylaxis once again, followed by the application of aPDT. Antimicrobial photodynamic therapy was applied to 31 orally healthy volunteers with black stained teeth, using the GLO home whitening device (GLO™ Science LLC, New York, USA) in 2 cycles of 8 minutes. Outcome variables were area, color and time taken to reappearance of black stain following dental prophylaxis with and without antimicrobial photodynamic therapy. Differences in bacterial composition of black stain (specifically Aggregatibacter actinomycetemcomitans, Tannerella forsythia and Porphyromonas gingivalis) were analyzed DNA extracted from plaque samples. Following the application of aPDT, patients were reviewed monthly until the black stain score returned to the initial value.

02

Conditions studied

  • Dental Deposits
  • Tooth Discoloration
  • Dental Prophylaxis

Browse trials for

Keywords

  • photodynamic therapy
  • black-stain
  • Pigmented bacteria
  • Tannerella forsythia
03

In context

Tooth Discoloration

105 studies on the registry are indexed under Tooth Discoloration; 19 are open to participants now.

This study's enrollment of 31 is below the median of 48 across 97 interventional studies indexed under Tooth Discoloration.

Browse Tooth Discoloration studies →

Lead sponsor

Cardenal Herrera University is the lead sponsor of 107 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Volunteers with black stained (plaque on) teeth

Exclusion criteria

Exclusion Criteria:

  • Children
  • Pregnant women
  • Volunteers having completed antibiotic therapy during 15 days prior to the start of the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
31 participants (actual)

Study arms

  • Active comparator
    Dental Prophylaxis

    Standard dental prophylaxis

    Procedure: Dental prophylaxis

  • Active comparator
    Dental prophylaxis + antimicrobial photodynamic therapy

    Dental prophylaxis + aPDT

    Procedure: Dental prophylaxis · Device: Dental prophylaxis + antimicrobial photodynamic therapy

Interventions

  • ProcedureDental prophylaxis

    American Dental Association, Code on Dental Procedures and Nomenclature (CDT) CDT code D1110

  • DeviceDental prophylaxis + antimicrobial photodynamic therapy

    Dental prophylaxis using American Dental Association, Code on Dental Procedures and Nomenclature (CDT) CDT code D1110 followed by two 8-minute irradiation cycles using GLO Brilliant home use whitening device (GLO ™ Science LLC, New York, USA).

06

What researchers measure

Primary outcomes

  1. Restoration period

    Time to restoration of the black stain following each treatment arm

    Time frame: The period of time required for the restoration of the black stain to pre-cleaning levels will be determined by measurements carried out during Weeks 18-24, post-application of each treatment arm

Secondary outcomes

  1. Black stain color

    Color of the black stain

    Time frame: The depth of color of the black stain will be measured at Week 20 following the application of each treatment arm

  2. Black stain area

    Area covered by the black stain

    Time frame: Area covered by the black stain will be carried out at Week 20 following the application of each treatment arm

  3. Microbial composition

    Microbial composition of the black plaque

    Time frame: Black plaque sampling will be carried out at Week 0, followed by a second sampling at Week 20, following the application of each treatment arm, in accordance with the reappearance rate of the black stain in each study volunteer

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Albelda-Bernardo MA, Jovani-Sancho MDM, Veses V, Sheth CC. Remediation of adult black dental stains by phototherapy. BDJ Open. 2018 Apr 11;4:17035. doi: 10.1038/s41405-018-0001-9. eCollection 2018. PubMed 29977603 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2014 to primary completion in Apr 2016, 23 months.

Of 44 non-industry interventional studies with no phase under Tooth Discoloration, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 21. This study's 23 months is above that.

Counting every sponsor, half of 52 studies reached it within 8 months; a quarter within 2 and three quarters within 18.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2017
First posted
Oct 16, 2017
StartActual
May 5, 2014
Primary completionActual
Apr 30, 2016
CompletionActual
Apr 30, 2016
Last update
Dec 17, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03309748
Responsible party
Chirag Sheth (Associate Professor, Cardenal Herrera University) — Principal investigator
First posted
Oct 16, 2017
Start date
May 5, 2014
Primary completion
Apr 30, 2016
Completion
Apr 30, 2016
Last update
Dec 17, 2024

Study contacts

Maria del Mar Jovani Sancho, PhD
study director · Cardenal Herrera University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion